HOME >> BIOLOGY >> NEWS
Scientists move closer to bio-engineered bladders

Researchers at the University of York are using an understanding of the special cells that line the bladder to develop ways of restoring continence to patients with serious bladder conditions, including cancer. The research, highlighted in the quarterly magazine of the Biotechnology and Biological Sciences Research Council (BBSRC) this week, is looking at urothelial cells. These are the specialised lining cells of the bladder that enable it to retain urine. The cells have a very low turnover rate, but scientists have found that if the bladder is damaged, the urothelial cells are able to rapidly re-grow to repair the wound. The researchers hope to harness this property to engineer new bladders.

The York researchers have developed a series of models that mean they can study human urothelial cells in the laboratory. Of these models, the most important is their development of a urothelial cell sheet that functions as it would in the bladder. When the researchers create a wound in this model, the cells regenerate to repair the damage - just as they would in the body.

Pharmaceutical companies should soon be able to use the research models to test therapies for the bladder, but the longer term aim for this research is to help patients who have lost bladder function or have had all or part of their bladder removed because of cancer.

Research leader, Professor Jenny Southgate, explains: "The models we have developed mean that we have been able to examine how urothelial cells in the bladder self-renew to cope with injury.

"With this basic understanding of how the cells work, we are moving towards being able to engineer new bladders. Currently, substitute bladders can be created by using a section of the patient's bowel, but this can lead to complications, as the bowel does not have the same urine-holding properties as urothelial cells. One solution could be to use laboratory-grown urothelial cells to line a section of bowel."


'"/>

Contact: Matt Goode
press.office@bbsrc.ac.uk
01-793-413-299
Biotechnology and Biological Sciences Research Council
31-Jul-2007


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists find stem cell switch
4. Scientists discover new way to study nanostructures
5. Scientists a step closer to understanding how anaesthetics work in the brain
6. Scientists to make news at Computational Biology Conference
7. Accident-prone? Scientists link brain function to knee injuries
8. Scientists take next step in understanding potential target for ovarian cancer treatment
9. Scientists find brown fat master switch
10. Scientists identify 2 distinct Parkinsons networks
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... Amplify Surgical, ... with the dualX Expanding Interbody Fusion System. , The landmark case was ... After the case Dr. Najafi noted, “dualX has completely changed the game for ...
(Date:3/2/2020)... , ... March 02, 2020 , ... Philadelphia IP law ... Bliss, Ph.D., J.D. has joined the firm as a Partner, and Stephany G. Small, ... an experienced patent attorney and will be a partner in the firm’s biotechnology and ...
(Date:2/28/2020)... ... , ... Meridian Clinical Research , a leading investigative research network, is ... Best Clinical Trial Site. Meridian is also the largest member of Platinum Research ... nominations were the result of two voting rounds, and winners will be announced at ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a global leader ... announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen in a gel testing ... run on ORTHO VISION® and ORTHO VISION® Max in the United States and Canada. ...
(Date:3/4/2020)... ... March 04, 2020 , ... ... recombinant antibody products and services, today announced the launch of its FleXpress™ ... express a large number of antibodies at 80 ml scale. All production ...
(Date:3/3/2020)... , ... March 03, 2020 , ... ... invited to present the latest breast implant technology at the IMCAS Innovation Shark ... new innovations in the dermatology, plastic surgery, and aesthetic science industries that promise ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing its leading ... the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) HMO. ... milk. These complex carbohydrates are indigestible and therefore function as a prebiotic by ...
Breaking Biology Technology:
Cached News: